Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
widely prescribed off-label for medically supervised obesity management Cardiovascular Protection Clinically proven to reduce risk of major cardiac events in adults with type 2 diabetes and established heart disease Once-Weekly Convenience A single prefilled pen injection every 7 days
Icotrokinra binds the IL-23 receptor (IL-23R) with single-digit picomolar affinity, showing exceptional potency and selectivity in blocking IL-23driven signaling within human T cells
There is currently no official FDA indication or established clinical evidence that tirzepatide directly treats erectile dysfunction
SLU-PP-332/5-Amino-1MQ/BPC-157 This oral tablet combines three distinct compounds SLU-PP-332, 5-Amino-1MQ, and BPC-157 each selected for its unique biological activity
US$ 20.95
![Efficacy of tirzepatide in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1](https://www.researchgate.net/publication/363201315/figure/fig3/AS:11431281082605778@1662084799021/Efficacy-of-tirzepatide-in-phase-2-GPGB-14-and-phase-3-SURPASS-1-to-5-15-19.png)
US$ 23.03
US$ 25.30
